X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TEVA PHARMA (Israel) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   TEVA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-18
TEVA PHARMA
Dec-13
PIRAMAL ENTERPRISES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,0833,001-   
Low Rs1,9022,607-   
Sales per share (Unadj.) Rs589.71,722.1-  
Earnings per share (Unadj.) Rs284.0107.6-  
Cash flow per share (Unadj.) Rs310.5246.8-  
Dividends per share (Unadj.) Rs25.0094.18-  
Dividend yield (eoy) %1.03.4 29.9%  
Book value per share (Unadj.) Rs1,467.01,913.0-  
Shares outstanding (eoy) m180.27848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x4.21.6 259.6%   
Avg P/E ratio x8.826.1 33.7%  
P/CF ratio (eoy) x8.011.4 70.7%  
Price / Book Value ratio x1.71.5 115.9%  
Dividend payout %8.887.5 10.1%   
Avg Mkt Cap Rs m449,3322,377,546 18.9%   
No. of employees `0006.844.9 15.2%   
Total wages/salary Rs m19,8810-   
Avg. sales/employee Rs Th15,535.632,492.5 47.8%   
Avg. wages/employee Rs Th2,905.40-   
Avg. net profit/employee Rs Th7,482.52,029.8 368.6%   
INCOME DATA
Net Sales Rs m106,3101,460,373 7.3%  
Other income Rs m2,5950-   
Total revenues Rs m108,9061,460,373 7.5%   
Gross profit Rs m51,599399,924 12.9%  
Depreciation Rs m4,773118,043 4.0%   
Interest Rs m29,78328,684 103.8%   
Profit before tax Rs m19,638253,197 7.8%   
Minority Interest Rs m2,8011,150 243.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-166,210 0.0%   
Tax Rs m-28,764-3,091 930.5%   
Profit after tax Rs m51,20391,228 56.1%  
Gross profit margin %48.527.4 177.2%  
Effective tax rate %-146.5-1.2 11,997.3%   
Net profit margin %48.26.2 771.0%  
BALANCE SHEET DATA
Current assets Rs m118,154986,331 12.0%   
Current liabilities Rs m462,260860,164 53.7%   
Net working cap to sales %-323.78.6 -3,746.6%  
Current ratio x0.31.1 22.3%  
Inventory Days Days2791 29.3%  
Debtors Days Days4796 48.5%  
Net fixed assets Rs m113,727476,990 23.8%   
Share capital Rs m3613,595 10.0%   
"Free" reserves Rs m264,0930-   
Net worth Rs m264,4541,622,198 16.3%   
Long term debt Rs m242,206746,721 32.4%   
Total assets Rs m726,8343,337,421 21.8%  
Interest coverage x1.79.8 16.9%   
Debt to equity ratio x0.90.5 199.0%  
Sales to assets ratio x0.10.4 33.4%   
Return on assets %11.13.6 310.1%  
Return on equity %19.45.6 344.3%  
Return on capital %10.34.9 209.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,8130-   
CASH FLOW
From Operations Rs m-159,666232,708 -68.6%  
From Investments Rs m-17,677-82,458 21.4%  
From Financial Activity Rs m186,503-279,149 -66.8%  
Net Cashflow Rs m9,364-128,899 -7.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PIRAMAL ENTERPRISES With: PLETHICO PHARMA  JUBILANT LIFE SCIENCES  FDC LTD.  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Indian Indices End Week Strong, Pharma Stocks Show Uptick(Pre-Open)

On Friday, share markets in India opened on a positive note and ended the day in green after a volatile day of trading.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY19); Net Profit Down 152.5% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 1 bn (down 152.5% YoY). Sales on the other hand came in at Rs 29 bn (up 28.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Nov 16, 2018 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS